Our results clearly indicate that significant alterations occur in the levels of circulating CS/DS, IGF-1, and IGFBP-3 in children with untreated JIA, and these changes are sensitive to anti-inflammatory treatment. The gene discussed is IGFBP3; the disease is juvenile idiopathic arthritis.